Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. scores highest on Torque (70) and lowest on Nitro (25). Its PosiPenta is 42.70 out of 100, around the middle of similar companies.
On the Penta Grid this week, Avalo Therapeutics, Inc. is Grid #444 of 837 in the Healthcare sector in United States, and Grid #2,619 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 42.70 | 35 | 32 | 25 | 70 | 51 |
| Carlsmed, Inc. | 45.64 | 16 | 31 | 78 | 40 | 64 |
| Indaptus Therapeutics, Inc. | 41.18 | 2 | 41 | 50 | 49 | 63 |
| Orthofix Medical Inc. | 49.69 | 41 | 62 | 46 | 48 | 52 |
| Senseonics Holdings, Inc. | 39.33 | 15 | 30 | 73 | 24 | 54 |
| C4 Therapeutics, Inc. | 39.88 | 34 | 36 | 55 | 45 | 29 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.61 |
| P/B ratio | 1.35 |
EEarnings
| Trailing EPS | ₹-408.22 |
| Forward EPS | ₹-256.58 |
NNitro
| Price | 1067.44 |
| 52-week high | 2298.73 |
| 52-week low | 1064.12 |
| Fall from 52-week high | 53.6% |
TTorque
| Return on equity (ROE) | -36.27% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.69 |
| Market cap | ₹5,724 Cr |
| Insider holding | 1.69% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Avalo Therapeutics, Inc.'s PosiPenta score?
Avalo Therapeutics, Inc.'s PosiPenta is 42.70 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Avalo Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Avalo Therapeutics, Inc. is Grid #444 of 837 in the Healthcare sector in United States, and Grid #2,619 of 4,000 in United States.
Which PosiPenta pillar is strongest for Avalo Therapeutics, Inc.?
Torque (durability), with a score of 70 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Avalo Therapeutics, Inc.?
Nitro (momentum), with a score of 25 out of 100: weaker than most similar companies.
Has Avalo Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.34 points, from 41.36 to 42.70.
PositoAI is for research and education only and is not investment advice.